What Is Glucagon?
Published Jul 1, 2026 · 4 minute read
Glucagon is the hormone that raises your blood sugar, the opposite of insulin. So why would the most advanced weight and liver drugs deliberately switch its receptor on? The answer is one of the more counterintuitive ideas in metabolic medicine, and it explains the whole “triple agonist” category.
Key Takeaways
- Glucagon is a pancreatic hormone that raises blood sugar, the mirror image of insulin.
- Glucagon is not an incretin, but it is closely related to GLP-1 in biology and naming.
- Activating the glucagon receptor increases energy expenditure and liver fat oxidation.
- Newer drugs pair glucagon receptor activity with GLP-1 to balance the blood-sugar effect.
- Glucagon receptor activity is used by GLP-1/glucagon dual agonists and triple agonists.
- This page is educational and is not medical advice.
1. What Is Glucagon?
Glucagon is a hormone produced by the alpha cells of the pancreas. Its classic job is to raise blood sugar: when glucose runs low, glucagon signals the liver to release stored sugar back into the bloodstream. In that sense it is the mirror image of insulin, which lowers blood sugar.
Glucagon is not an incretin. But it is deeply tied to the GLP-1 story, because GLP-1’s full name, glucagon-like peptide-1, reflects that the two molecules come from the same biological family.
| Term | What it means |
|---|---|
| Glucagon | A pancreatic hormone that raises blood sugar. |
| Glucagon receptor | The cell receptor glucagon binds to; targeted by some modern drugs. |
| Insulin | The hormone that lowers blood sugar; glucagon’s counterpart. |
| Energy expenditure | The calories the body burns; increased by glucagon receptor activity. |
2. Glucagon vs Insulin
Glucagon and insulin form a balancing pair that keeps blood sugar in a healthy range.
| Hormone | Effect on blood sugar | Released when |
|---|---|---|
| Insulin | Lowers it | Blood sugar is high (after eating) |
| Glucagon | Raises it | Blood sugar is low (fasting) |
This opposition is exactly why pairing a glucagon receptor agonist with a GLP-1 receptor agonist is clever: GLP-1 helps counterbalance glucagon’s blood-sugar-raising effect.
3. The Counterintuitive Part
If glucagon raises blood sugar, activating its receptor sounds like the last thing a metabolic drug should do. The reason it can still help comes down to glucagon’s other effects:
- Increased energy expenditure: glucagon receptor activity can raise the number of calories the body burns.
- Liver fat oxidation: glucagon acts directly on the liver to burn fat, which is the rationale behind targeting it in liver disease like MASH.
Drugs solve the blood-sugar problem by combining glucagon activity with GLP-1 activity, so the appetite-reducing, glucose-lowering GLP-1 arm offsets glucagon’s downside.
4. Which Drugs Target the Glucagon Receptor
| Drug | Glucagon action | Other receptors | Status |
|---|---|---|---|
| Survodutide | Glucagon agonist | GLP-1 | Investigational |
| Pemvidutide | Glucagon agonist (balanced ~1:1) | GLP-1 | Investigational |
| Efinopegdutide | Glucagon agonist | GLP-1 | Investigational |
| Retatrutide | Glucagon agonist | GIP + GLP-1 | Investigational |
The first three are GLP-1/glucagon dual agonists. Retatrutide is the triple agonist, adding glucagon on top of the GIP and GLP-1 incretin pair.
Stacking receptors is the simplest way to picture how the field has progressed: from one target, to two, to three.
5. Why It Matters
Glucagon is the third hormone, after GLP-1 and GIP, that defines the modern drug landscape. Once you understand that glucagon burns fat and energy even as it raises blood sugar, the logic of GLP-1/glucagon and triple agonists becomes clear: combine complementary hormones so the benefits add up and the downsides cancel out.
- Glucagon = a pancreatic hormone that raises blood sugar.
- Not an incretin, but closely related to GLP-1.
- Glucagon receptor activity = more energy burned and liver fat oxidized.
- Paired with GLP-1 in dual and triple agonist drugs to balance blood sugar.
6. What Is Glucagon FAQ
What is glucagon in simple terms?
Glucagon is a hormone made by the pancreas that raises blood sugar, mainly by telling the liver to release stored glucose. It works opposite to insulin, which lowers blood sugar.
Is glucagon an incretin?
No. The recognized human incretins are GLP-1 and GIP. Glucagon is a related pancreatic hormone, and GLP-1 is even named after it (glucagon-like peptide-1), but glucagon itself is not classified as an incretin.
Why would a weight-loss drug activate glucagon if it raises blood sugar?
Glucagon receptor activation also increases energy expenditure and helps the liver burn fat. Drugs pair it with GLP-1, which lowers blood sugar and curbs appetite, so the combined effect supports weight and liver goals while keeping glucose in check. This page does not make clinical claims about any product.
Which drugs target the glucagon receptor?
GLP-1/glucagon dual agonists such as survodutide, pemvidutide, and efinopegdutide target the glucagon receptor alongside GLP-1. The triple agonist retatrutide adds glucagon to GIP and GLP-1 activity.
What is the difference between glucagon and glucagon-like peptide-1?
They come from the same biological family and share part of their structure, which is why GLP-1 is named glucagon-like. But they do different jobs: glucagon raises blood sugar, while GLP-1 lowers it and reduces appetite.